Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 15NIH 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Lymphoma 24Leukemia 18Sarcoma 17Neuroblastoma 13Central Nervous System Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Hodgkin Disease 9Breast Neoplasms 9Brain Neoplasms 9Burkitt Lymphoma 7Malignant mesenchymal tumor 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Monocytic, Acute 6Rhabdomyosarcoma 5Ovarian Neoplasms 5Multiple Myeloma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Kidney Neoplasms 5Testicular Neoplasms 4Teratoma 4Neutropenia 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Lung Neoplasms 4Leukemia, Biphenotypic, Acute 4Endometrial Neoplasms 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Paclitaxel 20Carboplatin 18Cisplatin 12Topotecan 6Docetaxel 5Gemcitabine 4Etoposide 3rubitecan 2Taxes 2Surgical Procedures, Operative 2Filgrastim 2Erlotinib Hydrochloride 2Cyclophosphamide 2vandetanib 1sargramostim 1pegfilgrastim 1motesanib diphosphate 1liposomal doxorubicin 1liposomal amphotericin B 1Watchful Waiting 1Vorinostat 1Trabectedin 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Ondansetron 1Neoadjuvant Therapy 1Mitoxantrone 1Mifepristone 1Mass Spectrometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Ovarian Epithelial × Filgrastim × Clear all
NCT00569673 2018-07-18

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

GOG Foundation

Phase 2 Completed
71 enrolled 8 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003382 2013-06-10

Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer

GOG Foundation

Phase 1 Terminated
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡